Australia markets closed

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
13.65+0.04 (+0.29%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close13.61
Bid0.00 x 0
Ask0.00 x 0
Day's range13.59 - 13.73
52-week range12.45 - 18.45
Avg. volume693,141
Market cap53.956B
Beta (5Y monthly)1.15
PE ratio (TTM)12.41
Earnings dateN/A
Forward dividend & yield0.53 (3.86%)
Ex-dividend date02 May 2022
1y target estN/A
  • PR Newswire

    Bayer Monsanto Roundup Cancer Victims Oppose Settlement

    The Fears Nachawati law firm is asking a federal judge to reject a proposed settlement between Bayer (OTCMKTS: BAYZF, BAYRY) and its Monsanto subsidiary and a group of consumers seeking reimbursement for their purchases of the Roundup weedkiller, saying the agreement may be the result of collusion designed to limit the ability of cancer victims to obtain justice.

  • PR Newswire

    Judicial Panel Rejects Bayer Monsanto Attempt to Thwart Fair Settlement for Roundup-Cancer Victims

    A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits under terms that threatened to restrict much larger multidistrict litigation (MDL) over the herbicide Roundup, potentially affecting thousands of cancer victims and even those not yet diagnosed.

  • Business Wire

    Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures

    LEVERKUSEN, Germany & EMERYVILLE, Calif., September 14, 2021--Leaps by Bayer, the impact investment arm of Bayer AG, today announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.